Clinical Trial Update: Effect of Two Different Doses of Dexmedetomidine Infusion in Morbidly Obese Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing two different doses of dexmedetomidine infusion in morbidly obese patients undergoing anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia
• Obesity Morbid

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Tanta University | Conditions: Anesthesia, Obesity, Morbid | Phase 4 | Status: COMPLETED